Jazz Pharmaceuticals agreed to divest its Sunosi (solriamfetol) drug to Axsome Therapeutics that includes an upfront payment of $53 million.
Earlier research has shown that several of the same risk factors behind the development of cardiovascular disease also can lead to Alzheimer’s.
Even after causing havoc for last two years, coronavirus seems to have been refusing to die down.
The FDA has approved UCB’s Fintepla (flenfuramine) for patients two years and older experiencing seizures associated with Lennox-Gastaut syndrome.